Role of Proteasomes in Cellular Regulation

International Review of Cell and Molecular Biology

Volumn 267, Issue , 2008, Pages 59-124

  Konstantinova, Irina M ^a   Tsimokha, Anna S ^a   Mittenberg, Alexey G ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Apoptosis; Cell cycle; Different levels of gene expression; Differentiation; Immune response; Proteasome

Indexed keywords

MESSENGER RNA; PEPTIDASE; PROTEASOME; RIBONUCLEASE; ATP DEPENDENT 26S PROTEASE; PEPTIDE HYDROLASE; PROTEIN SUBUNIT; UBIQUITIN;

APOPTOSIS; CELL COMPARTMENTALIZATION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; ENZYME SUBUNIT; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; KNOWLEDGE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RNA STABILITY; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNE SYSTEM; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN PROCESSING;

EUKARYOTA;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; RIBONUCLEASES; RNA STABILITY; UBIQUITIN;

EID: 48949085430     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1937-6448(08)00602-3     Document Type: Review

References (334)

1. Abramova E.B., Sharova N.P., and Karpov V.L. The proteasome: Destroy to live. Mol. Biol. (Mosk). 36 (2002) 761-776
2. Abramova E.B., Astakhova T.M., and Sharova N.P. Changes in proteasome activity and subunit composition during postnatal development of rat. Ontogenes 36 (2005) 205-210
3. Adams J. Proteasome inhibitors as new anticancer drugs. Curr. Opin. Oncol. 14 (2002) 628-634
4. Adams J. Potential for proteasome inhibition in the treatment of cancer. Drug Discov. Today 8 (2003) 307-315
5. Adams J. The proteasome: Structure, function, and role in the cell. Cancer Treat. Rev. 1 (2003) 3-9
6. Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamondon L., and Stein R.L. Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids. Bioorg. Med. Chem. Lett. 8 (1998) 333-338
7. Adams J., Palombella V.J., Sausville E.A., Johnson J., Destree A., Lazarus D.D., Maas. J., Pien C.S., Prakash S., and Elliott P.J. Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Res. 59 (1999) 2615-2622
8. Adams J., Palombella V.J., and Elliott P.J. Proteasome inhibition: A new strategy in cancer treatment. Invest. New Drugs 18 (2000) 109-121
9. Adrain C., Creagh E.M., Cullen S.P., and Martin S.J. Caspase-dependent inactivation of proteasome function during programmed cell death in Drosophila and man. J. Biol. Chem. 279 (2004) 36923-36930
10. Ahn J.Y., Hong S.O., Kwak K.B., Kang S.S., Tanaka K., Ichihara A., Ha D.B., and Chung C.H. Developmental regulation of proteolytic activities and subunit pattern of 20S proteasome in chick embryonic muscle. J. Biol. Chem. 266 (1991) 15746-15749
11. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., Tanahashi N., Yoshimura T., Tanaka K., and Ichihara A. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. (Tokyo) 115 (1994) 257-269
12. An B., Goldfarb R.H., Siman R., and Dou Q.P. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death. Differ. 5 (1998) 1062-1075
13. Apcher G.S., Heink S., Zantopf D., Kloetzel P.M., Schmid H.P., Mayer R.J., and Kruger E. Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett. 553 (2003) 200-204
14. Arendt C.S., and Hochstrasser M. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc. Natl. Acad. Sci. USA 94 (1997) 7156-7161
15. Arendt C.S., and Hochstrasser M. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J. 18 (1999) 3575-3585
16. Auld K.L., and Silver P.A. Transcriptional regulation by the proteasome as a mechanism for cellular protein homeostasis. Cell Cycle 5 (2006) 1503-1505
17. Auld K.L., Brown C.R., Casolari J.M., Komili S., and Silver P.A. Genomic association of the proteasome demonstrates overlapping gene regulatory activity with transcription factor substrates. Mol. Cell 21 (2006) 861-871
18. Baldassarre G., Boccia A., Bruni P., Sandomenico C., Barone M.V., Pepe S., Angrisano T., Belletti B., Motti M.L., Fusco A., and Viglietto G. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ. 11 (2000) 517-526
19. Ballut L., Petit F., Mouzeeyar S., Le Gall O., Candresse T., Schmid P., Nicolas P., and Badaoui S. Biochemical identification of proteasome-associated endonuclease activity in sunflower. Biochem. Biophys. Acta 1645 (2003) 30-39
20. Bandyopadhyay G., Biswas T., Roy K.C., Mandal S., Mandal C., Pal B.C., Bhattacharya S., Rakshit S., Bhattacharya D.K., Chaudhuri U., Konar A., and Bandyopadhyay S. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104 (2004) 2514-2522
21. Baugh J.M., and Pilipenko E.V. 20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol. Cell 16 (2004) 575-586
22. Baumeister W., Walz J., Zuhl F., and Seemuller E. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92 (1998) 367-380
23. Baz A., Henry L., Chateau M.T., Scherrer K., and Bureau J.P. Subcellular distribution and profiles of prosomes (proteasomes-MCP) during differentiation of human lymphoblastic cell line. Leuk. Res. 21 (1997) 1061-1070
24. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., and Gygi S.P. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 12130-12135
25. Benedict C.M., Ren L., and Clawson G.A. Nuclear multicatalytic proteinase α subunit RRC3: Differential size, tyrosine phosphorylation, and susceptibility to antisense oligonucleotide treatment. Biochemistry 34 (1995) 9587-9598
26. Beyette J., Mason G.G., Murray R.Z., Cohen G.M., and Rivett A.J. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. Biochem. J. 332 (1998) 315-320
27. Blondel M., Galan J.M., Chi Y., Lafourcade C., Longaretti C., Deshaies R.J., and Peter M. Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4. EMBO J. 19 (2000) 6085-6097
28. Cip1 during S-phase. J. Biol. Chem. 278 (2003) 25752-25757
29. Bose S., Mason G.G., and Rivett A.J. Phosphorylation of proteasomes in mammalian cells. Mol. Biol. Rep. 26 (1999) 11-14
30. Bose S., Brooks P., Mason G.G., and Rivett A.J. γ-Interferon decreases the level of 26S proteasomes and changes the pattern of phosphorylation. Biochem. J. 353 (2001) 291-297
31. Bose S., Stratford F.L., Broadfoot K.I., Mason G.G., and Rivett A.J. Phosphorylation of 20S proteasome alpha subunit C8 (α7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by γ-interferon. Biochem. J. 378 (2004) 177-184
32. Bowerman B., and Kurz T. Degrade to create: Developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis. Development 133 (2006) 773-784
33. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., and Dimmeler S. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway. Mol. Cell Biol. 20 (2000) 1886-1896
34. Breitschopf K., Zeiher A.M., and Dimmeler S. Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J. Biol. Chem. 275 (2000) 21648-21652
35. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., and Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 276 (2001) 30057-30063
36. Bureau J.P., Henry L., Baz A., Scherrer K., and Chateau M.T. Prosomes (proteasomes) changes during differentiation are related to the type of inducer. Mol. Biol. Rep. 24 (1997) 57-62
37. Burns T.F., and El-Deiry W.S. The p53 pathway and apoptosis. J. Cell Physiol. 181 (1999) 231-239
38. Canu N., Barbato C., Ciotti M.T., Serafino A., Dus L., and Calissano P. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20 (2000) 589-599
39. Castano J.G., Mahillo E., Arizti P., and Arribas J. Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. Biochemistry 35 (1996) 3782-3789
40. Castro A., Arlot-Bonnemains Y., Vigneron S., Labbe J.C., Prigent C., and Lorca T. APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep. 3 (2002) 457-462
41. Castro A., Vigneron S., Bernis C., Labbe J.C., and Lorca T. Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway. Mol. Cell Biol. 23 (2003) 4126-4138
42. Chang Y.C., Lee Y.S., Tejima T., Tanaka K., Omura S., Heintz N.H., Mitsui Y., and Magae J. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 9 (1998) 79-84
43. Cip1/WAF1, and Bax proteins. J. Biol. Chem. 279 (2004) 13496-13505
44. Cheng L., Hunke L., and Hardy C.F. Cell cycle regulation of the Saccharomyces cerevisiae polo-like kinase cdc5p. Mol. Cell Biol. 18 (1998) 7360-7370
45. Cho J.W., Park J.C., Lee J.C., Kwon T.K., Park J.W., Baek W.K., Suh S.I., and Suh M.H. The levels of MDM2 protein are decreased by a proteasome-mediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages. J. Korean Med. Sci. 16 (2001) 135-139
46. Ciechanover A., and Schwartz A.L. The ubiquitin system: Pathogenesis of human diseases and drug targeting. Biochim. Biophys. Acta 1695 (2004) 3-17
47. Ciftci O., Ullrich O., Schmidt C.A., Diestel A., and Hass R. Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood 97 (2001) 2830-2838
48. Clarke D.J., Diaz-Martinez L.A., and Gimenez-Abian J.F. Anaphase promoting complex or cyclosome?. Cell Cycle 4 (2005) 1585-1592
49. Claverol S., Burlet-Schiltz O., Girbal-Neuhauser E., Gairin J.E., and Monsarrat B. Mapping and structural dissection of human 20S proteasome using proteomic approaches. Mol. Cell Proteomics 1 (2002) 567-578
50. Collins G.A., and Tansey W.P. The proteasome: A utility tool for transcription?. Curr. Opin. Genet. Dev. 16 (2006) 197-202
51. Contri A., Brunati A.M., Trentin L., Cabrelle A., Miorin M., Cesaro L., Pinna L.A., Zambello R., Semenzato G., and Donella-Deana A. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J. Clin. Invest. 115 (2005) 369-378
52. Coux O., Nothwang H.G., Silva Pereira I., Recillas Targa F., Bey F., and Scherrer K. Phylogenic relationships of the amino acid sequences of prosome (proteasome, MCP) subunits. Mol. Gen. Genet. 245 (1994) 769-780
53. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65 (1996) 801-847
54. Dahlmann B. Proteasomes. Essays Biochem. 41 (2005) 31-48
55. Dahlmann B., Ruppert T., Kuehn L., Merforth S., and Kloetzel P.M. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J. Mol. Biol. 303 (2000) 643-653
56. Dahlmann B., Ruppert T., Kloetzel P.M., and Kuehn L. Subtypes of 20S proteasomes from skeletal muscle. Biochimie 83 (2001) 295-299
57. Dawson S.P., Arnold J.E., Mayer N.J., Reynolds S.E., Billett M.A., Gordon C., Colleaux L., Kloetzel P.M., Tanaka K., and Mayer R.J. Developmental changes of the 26S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J. Biol. Chem. 270 (1995) 1850-1858
58. DeMartino G.N., Proske R.J., Moomaw C.R., Strong A.A., Song X., Hisamatsu H., Tanaka K., and Slaughter C.A. Identification, purification, and characterization of a PA700-dependent activator of the proteasome. J. Biol. Chem. 271 (1996) 3112-3118
59. Demasi M., Shringarpure R., and Davies K.J. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch. Biochem. Biophys. 389 (2001) 254-263
60. Demasi M., Silva G.M., and Netto L.E. 20S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J. Biol. Chem. 278 (2003) 679-685
61. Dembla-Rajpal N., Seipelt R., Wang Q., and Rymond B.C. Proteasome inhibition alters the transcription of multiple yeast genes. Biochim. Biophys. Acta 1680 (2004) 34-45
62. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
63. Deveraux Q.L., Roy N., Srennicke H.R., van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., and Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17 (1998) 2215-2223
64. Dimmeler S., Breitschopf K., Haendeler J., and Zeiher A.M. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway. J. Exp. Med. 189 (1999) 1815-1822
65. Donzelli M., Squatrito M., Ganoth D., Hershko A., Pagano M., and Draetta G.F. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 21 (2002) 4875-4884
66. Drexler H.C. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94 (1997) 855-860
67. Drexler H.C. Programmed cell death and the proteasome. Apoptosis 3 (1998) 1-7
68. Drexler H.C., Risau W., and Konerding M.A. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 14 (2000) 65-77
69. Dubiel W., Pratt G., Ferrell K., and Rechsteiner M. Purification of an 11S regulator of the multicatalytic proteinase. J. Biol. Chem. 267 (1992) 22369-22377
70. Duckett C.S., Nava V.E., Gedrich R.W., Clem R.J., Van Dongen J.L., Gilfillan M.C., Shiels H., Hardwick J.M., and Thompson C.B. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15 (1996) 2685-2694
71. Ebisui C., Tsujinaka T., Morimoto T., Fujita J., Ogawa A., Ishidoh K., Kominami E., Tanaka K., and Monden M. Changes of proteasomes and cathepsins activities and their expression during differentiation of C2C12 myoblasts. J. Biochem. (Tokyo) 117 (1995) 1088-1094
72. Egerer K., Kuckelkorn U., Rudolph P.E., Ruckert J.C., Dorner T., Burmester G.-R., Kloetzel P.M., and Feist E. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J. Rheumatol. 29 (2002) 2045-2052
73. Enenkel C., Lehmann A., and Kloetzel P.M. GFP-labelling of 26S proteasomes in living yeast: Insight into proteasomal functions at the nuclear envelope/rough ER. Mol. Biol. Rep. 26 (1999) 131-135
74. Ermonval M., Kitzmuller C., Mir A.M., Cacan R., and Ivessa N.E. N-glycan structure of a short-lived variant of ribophorin I expressed in the MadIA214 glycosylation-defective cell line reveals the role of a mannosidase that is not ER mannosidase I in the process of glycoprotein degradation. Glycobiology 11 (2001) 565-576
75. Evteeva I.N., Kulichkova V.A., Mittenberg A.G., Volkova I.V., Ermolaeva Iu.B., Teslenko L.V., Obukhova A.D., Penniiainen V.A., Gauze L.N., and Konstantinova I.M. Novel endoribonuclease activity of 26S proteasomes from A431 cells. Tsitologiia 42 (2000) 675-680 [in Russian].
76. Evteeva I.N., Kulichkova V.A., Obukhova A.D., Mittenberg A.G., Volkova I.V., Ermolaeva Iu.B., Toktarova M.V., Teslenko L.V., Gauze L.N., and Konstantinova I.M. EGF regulation of specific endoribonuclease activity of 26S proteasomes from A431 cells: A potential role of proteasomes in control of mRNA stability. Tsitologiia 45 (2003) 488-492 . [in Russian].
77. Ezhkova E., and Tansey W.P. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol. Cell 13 (2004) 435-442
78. Fang S., Jensen J.P., Ludwig R.L., Vousden K.H., and Weissman A.M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275 (2000) 8945-8951
79. Farout L., Mary J., Vinh J., Szweda L.I., and Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 453 (2006) 135-142
80. Feist E., Dorner T., Kuckelkorn U., Schmidtke G., Micheel B., Hiepe F., Burmester G.R., and Kloetzel P.M. Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J. Exp. Med. 184 (1996) 1313-1318
81. Feist E., Kuckelkorn U., Dorner T., Donitz H., Scheffler S., Hiepe F., Kloetzel P.M., and Burmester G.R. Autoantibodies in primary Sjogren's syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum. 42 (1999) 697-702
82. Feist E., Brychcy M., Hausdorf G., Hoyer B., Egerer K., Dorner T., Kuckelkorn U., and Burmester G.R. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells. Ann. Rheum. Dis. 66 (2007) 5-11
83. Feldman R.M., Correll C.C., Kaplan K.B., and Deshaies R.J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91 (1997) 221-230
84. Feng Y., Longo D.L., and Ferris D.K. Polo-like kinase interacts with proteasomes and regulates their activity. Cell Growth Differ. 12 (2001) 29-37
85. Fenteany G., and Schreiber S.L. Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273 (1998) 8545-8548
86. Ferdous A., Gonzalez F., Sun L., Kodadek T., and Johnston S.A. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 7 (2001) 981-991
87. Ferdous A., Sikder D., Gillette T., Nalley K., Kodadek T., and Johnston S.A. The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Dev. 21 (2007) 112-123
88. Fernandez-Murray P., Pardo P.S., Zelada A.M., and Passeron S. In vivo and in vitro phosphorylation of Candida albicans 20S proteasome. Arch. Biochem. Biophys. 404 (2002) 116-125
89. Ferreira M.F., Santocanale C., Drury L.S., and Diffley J.F. Dbf4p, an essential S phase-promoting factor, is targeted for degradation by the anaphase-promoting complex. Mol. Cell Biol. 20 (2000) 242-248
90. Fleming J.A., Lightcap E.S., Sadis S., Thoroddsen V., Bulawa C.E., and Blackman R.K. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc. Natl. Acad. Sci. USA 99 (2002) 1461-1466
91. Foucrier J., Grand M.C., De Conto F., Bassaglia Y., Geraud G., Scherrer K., and Martelly I. Dynamic distribution and formation of a para-sarcomeric banding pattern of prosomes during myogenic differentiation of satellite cells in vitro. J. Cell Sci. 112 (1999) 989-1001
92. Fraser R.A., Rossignol M., Heard D.J., Egly J.M., and Chambon P. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J. Biol. Chem. 272 (1997) 7122-7126
93. Froment C., Uttenweiler-Joseph S., Bousquet-Dubouch M.P., Matondo M., Borges J.P., Esmenjaud C., Lacroix C., Monsarrat B., and Burlet-Schiltz O. A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity. Proteomics 5 (1995) 2351-2363
94. Fruh K., Gossen M., Wang K., Bujard H., Peterson P.A., and Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: A newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13 (1994) 3236-3244
95. Fu H., Doelling J.H., Arendt C.S., Hochstrasser M., and Vierstra R.D. Molecular organization of the 20S proteasome gene family from Arabidopsis thaliana. Genetics 149 (1998) 677-692
96. Gao X., Li J., Pratt G., Wilk S., and Rechsteiner M. Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma). Arch. Biochem. Biophys. 425 (2004) 158-164
97. Gao Y., Lecker S., Post M.J., Hietaranta A.J., Li J., Volk R., Li M., Sato K., Saluja A.K., Steer M.L., Goldberg A.L., and Simons M. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. J. Clin. Invest. 106 (2000) 439-448
98. Garneau N.L., Wilusz J., and Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 8 (2007) 113-126
99. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., and Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153 (2001) 137-148
100. Gillardon F., Kloss A., Berg M., Neumann M., Mechtler K., Hengerer B., and Dahlmann B. The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activity. J. Neurochem. (2007) In press.
101. Gillette T.G., Gonzalez F., Delahodde A., Johnston S.A., and Kodadek T. Physical and functional association of RNA polymerase II and the proteasome. Proc. Natl. Acad. Sci. USA 101 (2004) 5904-5909
102. Glenn R.J., Pemberton A.J., Royle H.J., Spackman R.W., Smith E., Rivett J.A., and Steverding D. Trypanocidal effect of alpha',beta'-epoxyketones indicates that trypanosomes are particularly sensitive to inhibitors of proteasome trypsin-like activity. Int. J. Antimicrob. Agents. 24 (2004) 286-289
103. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
104. Glickman M.H., and Raveh D. Proteasome plasticity. FEBS Lett. 579 (2005) 3214-3223
105. Glickman M.H., Rubin D.M., Fried V.A., and Finley D. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol. Cell Biol. 18 (1998) 3149-3162
106. Gomes A.V., Zong C., Edmondson R.D., Li X., Stefani E., Zhang J., Jones R.C., Thyparambil S., Wang G.W., Qiao X., Bardag-Gorce F., and Ping P. Mapping the murine cardiac 26S proteasome complexes. Circ. Res. 99 (2006) 362-371
107. Gregory M.A., and Hann S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell Biol. 20 (2000) 2423-2435
108. Grimm L.M., Goldberg A.L., Poirier G.G., Schwartz L.M., and Osborne B.A. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15 (1996) 3835-3844
109. Groettrup M., Standera S., Stohwasser R., and Kloetzel P.M. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94 (1997) 8970-8975
110. Groettrup M., Khan S., Schwarz K., and Schmidtke G. Interferon-gamma inducible exchanges of 20S proteasome active site subunits: Why?. Biochimie 83 (2001) 367-372
111. Groettrup M., van den Broek M., Schwarz K., Macagno A., Khan S., de Giuli R., and Schmidtke G. Structural plasticity of the proteasome and its function in antigen processing. Crit. Rev. Immunol. 21 (2001) 339-358
112. Groll M., Ditzel L., Loewe J., Stock D., Bochtler M., Bartunik H.D., and Huber R. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386 (1997) 463-471
113. Groll M., Bajorek M., Kohler A., Moroder L., Rubin D.M., Huber R., Glickman M.H., and Finley D. A gated channel into the proteasome core particle. Nat. Struct. Biol. 7 (2000) 1062-1067
114. Groll M., and Huber R. Inhibitors of the eukaryotic 20S proteasome core particle: A structural approach. Biochim. Biophys. Acta. 1695 (2004) 33-44
115. Groll M., Bochtler M., Brandstetter H., Clausen T., and Huber R. Molecular machines for protein degradation. Chembiochem. 6 (2005) 222-256
116. Grune T., Jung T., Merker K., and Davies K.J. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36 (2004) 2519-2530
117. Grziwa A., Baumeister W., Dahlmann B., and Kopp F. Localization of subunits in proteasomes from Thermoplasma acidophilum by immunoelectron microscopy. FEBS Lett. 290 (1991) 186-190
118. Guo G.G., Gu M., and Etlinger J.D. 240-kDa proteasome inhibitor (CF-2) is identical to delta-aminolevulinic acid dehydratase. J. Biol. Chem. 269 (1994) 12399-12402
119. Haass C., and Kloetzel P.-M. The Drosophila proteasome undergoes changes in its subunit pattern during development. Exp. Cell Res. 180 (1989) 243-252
120. Hames R.S., Wattam S.L., Yamano H., Bacchieri R., and Fry A.M. APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box. EMBO J. 20 (2001) 7117-7127
121. Hayashi T., and Goto S. Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech. Ageing Dev. 102 (1998) 55-66
122. Heinemeyer W., Ramos P.C., and Dohmen R.J. The ultimate nanoscale mincer: Assembly, structure and active sites of the 20S proteasome core. Cell Mol. Life Sci. 61 (2004) 1562-1578
123. Heink S., Ludwig D., Kloetzel P.M., and Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. USA 102 (2005) 9241-9246
124. Henry L., Baz A., Chateau M.T., Caravano R., Scherrer K., and Bureau J.P. Proteasome (prosome) subunit variations during the differentiation of myeloid U937 cells. Anal. Cell Pathol. 15 (1997) 131-144
125. Herrmann J.L., Briones F., Brisbay S., Logothetis C.J., and McDonnell T.J. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Oncogene 17 (1998) 2889-2899
126. Hildebrandt E.R., and Hoyt M.A. Cell cycle-dependent degradation of the Saccharomyces cerevisiae spindle motor Cin8p requires APC(Cdh1) and a bipartite destruction sequence. Mol. Biol. Cell 12 (2001) 3402-3416
127. Hirsch T., Dallaporta B., Zamzami N., Susin S.A., Ravagnan L., Marzo I., Brenner C., and Kroemer G. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J. Immunol. 161 (1998) 35-40
128. Horiguchi R., Yoshikuni M., Tokumoto M., Nagahama Y., and Tokumoto T. Identification of a protein kinase which phosphorylates a subunit of the 26S proteasome and changes in its activity during meiotic cell cycle in goldfish oocytes. Cell Signal. 17 (2005) 205-215
129. Hu G., Lin G., Wang M., Dick L., Xu R.M., Nathan C., and Li H. Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Mol. Microbiol. 59 (2006) 1417-1428
130. Hu Z., Zhang Z., Doo E., Coux O., Goldberg A.L., and Liang T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73 (1999) 7231-7240
131. Huang L., Jacob R.J., Pegg S.C., Baldwin M.A., Wang C.C., Burlingame A.L., and Babbitt P.C. Functional assignment of the 20S proteasome from Trypanosoma brucei using mass spectrometry and new bioinformatics approaches. J. Biol. Chem. 276 (2001) 28327-28339
132. Humbard M.A., Stevens Jr. S.M., and Maupin-Furlow J.A. Posttranslational modification of the 20S proteasomal proteins of the archaeon Haloferax volcanii. J. Bacteriol. 188 (2006) 7521-7530
133. Ichihara A., Tanaka K., Andoh T., and Shimbara N. Regulation of proteasome expression in developing and transformed cells. Adv. Enzyme Regul. 33 (1993) 173-180
134. Ichihara A., and Tanaka K. Roles of proteasomes in cell growth. Mol. Biol. Rep. 21 (1995) 49-52
135. Imajoh-Ohmi S., Kawaguchi T., Sugiyama S., Tanaka K., Omura S., and Kikuchi H. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217 (1995) 1070-1077
136. Iwafune Y., Kawasaki H., and Hirano H. Electrophoretic analysis of phosphorylation of the yeast 20S proteasome. Electrophoresis 23 (2002) 329-338
137. Jakob C., Egerer K., Liebisch P., Turkmen S., Zavrski I., Kuckelkorn U., Heider U., Kaiser M., Fleissner C., Sterz J., Kleeberg L., Feist E., et al. Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 109 (2007) 2100-2105
138. Janeway C.A., and Travers P. Immunobiology: The Immune System in Health and Disease (1994), Current Biology Ltd./Garland Publishing, New York
139. Jang H.Y., and Wek R.C. Phosphorylation of eIF2α reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280 (2005) 14189-14202
140. Jarrousse A.-S., Petit F., Kreutzer-Scmid K., Gaedigk R., and Schmid H.-P. Possible involvement of proteasomes (prosomes) in AUUUA-mediated mRNA decay. J. Biol. Chem. 274 (1999) 2399-2407
141. Jin J., Shirogane T., Xu L., Nalepa G., Qin J., Elledge S.J., and Harper J.W. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17 (2003) 3062-3074
142. Jin Z.H., Kurosu T., Yamaguchi M., Arai A., and Miura. O. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 24 (2005) 1973-1981
143. Jones M.E., Haire M.F., Kloetzel P.M., Mykles D.L., and Schwartz L.M. Changes in the structure and function of the multicatalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta. Dev. Biol. 169 (1995) 436-447
144. Johnson D.G., and Walker C.L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 295-312
145. Josefsberg L.B., Galiani D., Dantes A., Amsterdam A., and Dekel N. The proteasome is involved in the first metaphase-to-anaphase transition of meiosis in rat oocytes. Biol. Reprod. 62 (2000) 1270-1277
146. Josefsberg L.B., Kaufman O., Galiani D., Kovo M., and Dekel N. Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation. Biol. Reprod. 64 (2001) 871-878
147. Juang Y.L., Huang J., Peters J.M., McLaughlin M.E., Tai C.Y., and Pellman D. APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science 275 (1997) 1311-1314
148. Kaczowka S.J., and Maupin-Furlow J.A. Subunit topology of two 20S proteasomes from Haloferax volcanii. J. Bacteriol. 185 (2003) 165-174
149. Kaiser P., Sia R.A., Bardes E.G., Lew D.J., and Reed S.I. Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1. Genes Dev. 12 (1998) 2587-2597
150. Kanayama H., Tanaka K., Aki M., Kagawa S., Miyaji H., Satoh M., Okada F., Sato S., Shimbara N., and Ichihara A. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res. 51 (1991) 6677-6685
151. Kawahara H., Kasahara M., Nishiyama A., Ohsumi K., Goto T., Kishimoto T., Saeki Y., Yokosawa H., Shimbara N., Murata S., Chiba T., Suzuki K., et al. Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes. EMBO J. 19 (2000) 4144-4153
152. Kawahara H., Philipova R., Yokosawa H., Patel R., Tanaka K., and Whitaker M. Inhibiting proteasome activity causes overreplication of DNA and blocks entry into mitosis in sea urchin embryos. J. Cell Sci. 113 (2000) 2659-2670
153. Khan M.T., and Joseph S.K. Characterization of membrane-associated proteasomes in WB rat liver epithelial cells. Arch. Biochem. Biophys. 385 (2001) 99-107
154. Kim K.B., Myung J., Sin N., and Crews C.M. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency. Bioorg. Med. Chem. Lett. 9 (1999) 3335-3340
155. Kimura Y., Takaoka M., Tanaka S., Sassa H., Tanaka K., Polevoda B., Sherman F., and Hirano H. Nα-Acetylation and proteolytic activity of the yeast 20S proteasome. J. Biol. Chem. 275 (2000) 4635-4639
156. Kimura Y., Saeki Y., Yokosawa H., Polevoda B., Sherman F., and Hirano H. N-Terminal modifications of the 19S regulatory particle subunits of the yeast proteasome. Arch. Biochem. Biophys. 409 (2003) 341-348
157. King R.W., Deshaies R.J., Peters J.M., and Kirschner M.W. How the proteolysis drives the cell cycle. Science 274 (1996) 1652-1659
158. Kinyamu H.K., and Archer T.K. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor mediated transcription. Mol. Cell Biol. (2007) In press.
159. Kitagawa H., Tani E., Ikemoto H., Ozaki I., Nakano A., and Omura S. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett. 443 (1999) 181-186
160. Kleiman F.E., Wu-Baer F., Fonseca D., Kaneko S., Baer R., and Manley J.L. BRCA1/BARD1 inhibition of mRNA 30 processing involves targeted degradation of RNA polymerase II. Genes Dev. 19 (2005) 1227-1237
161. Klein U., Gernold M., and Kloetzel P.M. Cell-specific accumulation of Drosophila proteasomes (MCP) during early development. J. Cell Biol. 111 (1990) 2275-2282
162. Kloetzel P.M. The proteasome and MHC class I antigen processing. Biochim. Biophys. Acta 1695 (2004) 225-233
163. Kloetzel P.M., Soza A., and Stohwasser R. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response. Biol. Chem. 380 (1999) 293-297
164. Krogan N.J., Lam M.H.Y., Filingham J., Keogh M.-C., Gebbia M., Li J., Datta N., Cagney G., Buratowski S., Emili A., and Greenblatt J.F. Proteasome involvement in the repair of DNA double-strand breaks. Mol. Cell 16 (2004) 1027-1034
165. Kulichkova V.A., Mittenberg A.G., Ermolaeva Yu.B., Volkova I.V., Kozhukharova I.V., Gause L.N., and Konstantinova I.M. Specificity of the proteasome population secreted from cells into the culture medium. Dokl. Akad. Nauk 399 (2004) 503-506
166. Kulichkova V.A., Mittenberg A.G., Evteeva I.N., Toktarova M.V., Tsimokha A.S., Volkova I.V., Ermolaeva Yu.B., Gause L.N., and Konstantinova I.M. Selective effect of epidermal growth factor on endoribonuclease activity of various proteasome subpopulations in the A431 line cells. Tsitologiya 46 (2004) 525-529
167. Kumatori A., Tanaka K., Inamura N., Sone S., Ogura T., Matsumoto T., Tachikawa T., Shin S., and Ichihara A. Abnormally high expression of proteasomes in human leukemic cells. Proc. Natl. Acad. Sci. USA 87 (1990) 7071-7075
168. Kumeda S.I., Deguchi A., Toi M., Omura S., and Umezawa K. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. Anticancer Res. 19 (1999) 3961-3968
169. Lam Y.A., Lawson T.G., Velayutham M., Zweier J.L., and Pickart C.M. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 416 (2002) 763-767
170. Laroia G., Cuesta R., Brewer G., and Schneider R.J. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284 (1999) 499-502
171. Laroia G., Sarkar B., and Schneider R.J. Ubiquitin-dependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs. Proc. Natl. Acad. Sci. USA 99 (2002) 1842-1846
172. Lavabre-Bertrand T., Henry L., Carillo S., Guiraud I., Quali A., Dutaud D., Aubry L., Rossi J.-F., and Bureau J.P. Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer 92 (2001) 2493-2500
173. Lee D., Ezhkova E., Li B., Pattenden S.G., Tansey W.P., and Workman J.L. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcription factors. Cell 123 (2005) 423-436
174. Lee D.H., and Goldberg A.L. Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol. 8 (1998) 397-403
175. Lee M., Hyun D.H., Marshall K.A., Ellerby L.M., Bredesen D.E., Jenner P., and Halliwell B. Effect of overexpression of Bcl-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radic. Biol. Med. 31 (2001) 1550-1559
176. Leggett D.S., Hanna J., Borodovsky A., Crosas B., Schmidt M., Baker R.T., Walz T., Ploegh H., and Finley D. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 10 (2002) 495-507
177. Li B., and Dou Q.P. Bax degradation by the ubiquitin/proteasomedependent pathway: Involvement in tumor survival and progression. Proc. Natl. Acad. Sci. USA 97 (2000) 3850-3855
178. Li N., Lerea K.M., and Etlinger J.D. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Biochem. Biophys. Res. Commun. 225 (1996) 855-860
179. Lipford J.R., and Deshaies R.J. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell Biol. 5 (2003) 845-850
180. Lipford J.R., Smith G.T., Chi Y., and Deshaies R.J. A putative stimulatory role for turnover in gene expression. Nature 438 (2005) 113-116
181. Liu Y., Liu X., Zhang T., Luna C., Liton P.B., and Gonzalez P. Cytoprotective effects of proteasome beta5 subunit overexpression in lens epithelial cells. Mol. Vis. 13 (2007) 31-38
182. Lopes U.G., Erhardt P., Yao R., and Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272 (1997) 12893-12896
183. Low P., Bussell K., Dawson S.P., Billett M.A., Mayer R.J., and Reynolds S.E. Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta. FEBS Lett. 400 (1997) 345-349
184. Low P., Reynolds S.E., and Sass M. Proteolytic activity of 26s proteasomes isolated from muscles of the tobacco hornworm, Manduca sexta: Differences between surviving muscles and those undergoing developmentally programmed cell death. Acta Biol. Hung. 52 (2001) 435-442
185. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., and Huber R. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 268 (1995) 533-539
186. Ludemann R., Lerea K.M., and Etlinger J.D. Copurification of casein kinase II with 20S proteasomes and phosphorylation of a 30 kDa proteasome subunit. J. Biol. Chem. 268 (1993) 17413-17417
187. Lupas A., Zwickl P., and Baumeister W. Proteasome sequences in eubacteria. Trends Biochem. Sci. 19 (1994) 533-534
188. Lupas A.N., and Martin J. AAA proteins. Curr. Opin. Struct. Biol. 12 (2002) 746-753
189. Ma J., Katz E., and Belote J.M. Expression of proteasome subunit isoforms during spermatogenesis in Drosophila melanogaster. Insect Mol. Biol. 11 (2002) 627-639
190. Machiels B.M., Henfling M.E., Gerards W.L., Broers J.L., Bloemendal H., Ramaekers F.C., and Schutte B. Detailed analysis of cell cycle kinetics upon proteasome inhibition. Cytometry 28 (1997) 243-252
191. MacLaren A.P., Chapman R.S., Wyllie A.H., and Watson C.J. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ. 8 (2001) 210-218
192. Madding L.S., Michel J.K., Shockley K.R., Conners S.B., Epting K.L., Johnson M.R., and Kelly R.M. Role of the beta1 subunit in the function and stability of the 20S proteasome in the hyperthermophilic archaeon Pyrococcus furiosus. J. Bacteriol. 189 (2007) 583-590
193. Mannhaupt G., Schnall R., Karpov V., Vetter I., and Feldmann H. Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS Lett. 450 (1999) 27-34
194. Margottin-Goguet F., Hsu J.Y., Loktev A., Hsieh H.M., Reimann J.D., and Jackson P.K. Prophase destruction of Emi1 by the SCFβ-TrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4 (2003) 813-826
195. Martin M.C., Dransfield I., Haslett C., and Rossi A.G. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276 (2001) 45041-45050
196. Martinez J.S., Jeong D.E., Choi E., Billings B.M., and Hall M.C. Acm1 is a negative regulator of the CDH1-dependent anaphase-promoting complex/cyclosome in budding yeast. Mol. Cell Biol. 26 (2006) 9162-9176
197. Mason G.G., Hendil K.B., and Rivett A.J. Phosphorylation of proteasomes in mammalian cells. Identification of two phosphorylated subunits and the effect of phosphorylation on activity. Eur. J. Biochem. 238 (1996) 453-462
198. Mason G.G., Murray R.Z., Pappin D., and Rivett A.J. Phosphorylation of ATPase subunits of the 26S proteasome. FEBS Lett. 430 (1998) 269-274
199. Maupin-Furlow J.A., and Ferry J.G. A proteasome from the methanogenic archaeon Methanosarcina thermophila. J. Biol. Chem. 270 (1995) 28617-28622
200. Maupin-Furlow J.A., Humbard M.A., Kirkland P.A., Li W., Reuter C.J., Wright A.J., and Zhou G. Proteasomes from structure to function: Perspectives from Archaea. Curr. Top. Dev. Biol. 75 (2006) 125-169
201. McCutchen-Maloney S.L., Matsuda K., Shimbara N., Binns D.D., Tanaka K., Slaughter C.A., and DeMartino G.N. cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome. J. Biol. Chem. 275 (2000) 18557-18565
202. McGarry T.J., and Kirschner M.W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93 (1998) 1043-1053
203. Meiners S., Heyken D., Weller A., Ludwig A., Stangl K., Kloetzel P.M., and Kruger E. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J. Biol. Chem. 278 (2003) 21517-21525
204. Meng L., Kwok B.H., Sin N., and Crews C.M. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res. 59 (1999) 2798-2801
205. Mittenberg A.G., Kulichkova V.A., Medvedeva N.D., Penniiainen V.A., Gauze L.N., and Konstantinova I.M. Characteristics of endoribonuclease activity of proteasomes from K562 cells. I. Dependence of RNase activity of proteasome and alpha-RNP on conditions of endonucleolysis reaction. Tsitologiia 44 (2002) 181-187 [in Russian].
206. Mittenberg A.G., Kulichkova V.A., Medvedeva N.D., Volkova I.V., Ermolaeva B., and Konstantinova I.M. Properties of endoribonuclease activity of proteasomes from K562 cells. II. Analysis of specific mRNA nucleolysis by proteasomes. Tsitologiia 44 (2002) 357-363 . [in Russian].
207. Mittenberg A.G., Pugacheva I.V., Moiseeva T.N., Tsimokha A.S., Kulichkova V.A., Gause L.N., and Konstantinova I.M. Regulation of the specificity of the 26S proteasome endoribonuclease activity in K562 cells under the action of differentiation and apoptosis inducers. Cell Tiss. Biol. 1 (2007) 162-168
208. Nandi D., Tahiliani P., Kumar A., and Chandu D. The ubiquitin-proteasome system. J. Biosci. 31 (2006) 137-155
209. Naujokat C., and Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82 (2002) 965-980
210. WAF1/Cip1 in human immature leukemic cells. Eur. J. Haematol. 65 (2000) 221-236
211. Nederlof P.M., Wang H.-R., and Baumeister W. Nuclear localization signals of human and Thermoplasma proteasomal α subunits are functional in vitro. Proc. Natl. Acad. Sci. USA 92 (1995) 12060-12064
212. Orlowski M., Cardozo C., and Michaud C. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32 (1993) 1563-1572
213. Orlowski M., and Wilk S. Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch. Biochem. Biophys. 383 (2000) 1-16
214. Ossendorp F., Fu N., Camps M., Granucci F., Gobin S.J., van den Elsen P.J., Schuurhuis D., Adema G.J., Lipford G.B., Chiba T., Sijts A., Kloetzel P.M., et al. Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J. Immunol. 174 (2005) 7815-7822
215. Pajonk F., and McBride W.H. The proteasome in cancer biology and treatment. Radiat. Res. 156 (2001) 447-459
216. Pardo P.S., Murray P.F., Walz K., Franco L., and Passeron S. In vivo and in vitro phosphorylation of the α7/PRS1 subunit of Saccharomyces cerevisiae 20S proteasome: In vitro phosphorylation by protein kinase CK2 is absolutely dependent on polylysine. Arch. Biochem. Biophys. 349 (1998) 397-401
217. Patton E.E., Peyraud C., Rouillon A., Surdin-Kerjan Y., Tyers M., and Thomas D. SCFMet30-mediated control of the transcriptional activator Met4 is required for the G1-S transition. EMBO J. 19 (2000) 1613-1624
218. Pereira M.E., and Wilk S. Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. Arch. Biochem. Biophys. 283 (1990) 68-74
219. Perkins G., Drury L.S., and Diffley J.F. Separate SCF(CDC4) recognition elements target Cdc6 for proteolysis in S phase and mitosis. EMBO J. 20 (2001) 4836-4845
220. Petersen B.O., Wagener C., Marinoni F., Kramer E.R., Melixetian M., Lazzerini Denchi E., Gieffers C., Matteucci C., Peters J.M., and Helin K. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev. 14 (2000) 2330-2343
221. Petit F., Jarrousse A.-S., Boissonnet G., Dadet M.H., Buri J., Briand Y., and Schmid H.-P. Proteasome (prosome) associated endonuclease activity. Mol. Biol. Rep. 24 (1997) 113-117
222. Petit F., Jarrousse A.-S., Dahlman B., Sobek A., Hendil K.B., Buri J., Briand Y., and Schmid H.-P. Involvement of proteasomal subunits zeta and iota in RNA degradation. Biochem. J. 326 (1997) 93-98
223. Pleban E., Bury M., Mlynarczuk I., and Wojcik C. Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines. Folia Histochem. Cytobiol. 39 (2001) 133-134
224. Qiu J.H., Asai A., Chi S., Saito N., Hamada H., and Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20 (2000) 259-265
225. Rajkumar S.V., Richardson P.G., Hideshima T., and Anderson K.C. Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23 (2005) 630-639
226. Rao S., Porter D.C., Chen X., Herliczek T., Lowe M., and Keyomarsi K. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc. Natl. Acad. Sci. USA 96 (1999) 7797-7802
227. Rape M., and Jentsch S. Productive RUPture: Activation of transcription factors by proteasomal processing. Biochim. Biophys. Acta 1695 (2004) 209-213
228. Rechsteiner M., Hoffman L., and Dubiel W. The multicatalytic and 26S proteases. J. Biol. Chem. 268 (1993) 6065-6068
229. Rechsteiner M., Realini C., and Ustrell V. The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem. J. 345 (2000) 1-15
230. Reed S.I. The ubiquitin-proteasome pathway in cell cycle control. Results Probl. Cell Differ. 42 (2006) 147-181
231. Reid J., and Svejstrup J.Q. DNA damage-induced Def1-RNA polymerase II interaction and Def1 requirement for polymerase ubiquitylation in vitro. J. Biol. Chem. 279 (2004) 29875-29878
232. Reverte C.G., Ahearn M.D., and Hake L.E. CPEB degradation during Xenopus oocyte maturation requires a PEST domain and the 26S proteasome. Dev. Biol. 231 (2001) 447-458
233. Rivett A.J. Intracellular distribution of proteasomes. Curr. Opin. Immunol. 10 (1998) 110-114
234. Rivett A.J., Palmer A., and Knecht E. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J. Histoch. Cytochem. 40 (1992) 1165-1172
235. Rivett A.J., Bose S., Brooks P., and Broadfoot K.I. Regulation of proteasome complexes by γ-interferon and phosphorylation. Biochimie 83 (2001) 363-366
236. Rock K.L., and Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17 (1999) 739-779
237. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
238. Rockel T.D., Stuhlmann D., and von Mikecz A. Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J. Cell Sci. 118 (2005) 5231-5242
239. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.M., Polakiewicz R.D., and Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23 (2005) 94-101
240. Sabatini N., Di Pietro R., Rapino M., Sancilio S., Comani S., and Cataldi A. PI-3-kinase/NF-kappaB mediated response of Jurkat T leukemic cells to two different chemotherapeutic drugs, etoposide and TRAIL. J. Cell Biochem. 93 (2004) 301-311
241. Sadoul R., Fernandez P.A., Quiquerez A.L., Martinou I., Maki M., Schroter M., Becherer J.D., Irmler M., Tschopp J., and Martinou J.C. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15 (1996) 3845-3852
242. Salghetti S.E., Kim S.Y., and Tansey W.P. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J. 18 (1999) 717-726
243. Satoh K., Sasajima H., Nyoumura K., Yokosawa H., and Sawada H. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry 40 (2001) 314-319
244. Sawada M.T., Morinaga C., Izumi K., and Sawada H. The 26S proteasome assembly is regulated by a maturation-inducing hormone in starfish oocytes. Biochem. Biophys. Res. Commun. 254 (1999) 338-344
245. Scharf A., Rockel T.D., and von Mikecz A. Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem. Cell Biol. (2007) In press.
246. Schliephacke M., Kremp A., Schmid H.P., Kohler K., and Kull U. Prosomes (proteasomes) of higher plants. Eur. J. Cell Biol. 55 (1991) 114-121
247. Schmid H.P., Vallon R., Tomek W., Kreutzer-Schmid C., Pouch M.N., Badaoui S., Boissonnet G., Briand M., Briand Y., and Buri J. Glycosylation and deglycosylation of proteasomes (prosomes) from calf liver cells: High abundance of neuraminic acid. Biochimie (Paris) 75 (1993) 905-910
248. Schmidt F., Dahlmann B., Janek K., Kloss A., Wacker M., Ackermann R., Thiede B., and Jungblut P.R. Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approaches. Proteomics 6 (2006) 4622-4632
249. Schwartz L.M., and Truman J.W. Hormonal control of rates of metamorphic development in the tobacco hornworm Manduca sexta. Dev. Biol. 99 (1983) 103-114
250. Schwechheimer C., and Schwager K. Regulated proteolysis and plant development. Plant Cell Rep. 23 (2004) 353-364
251. Schweitzer K., Cocklin R., Garrett L., Desai F., and Goebl M. The ubiquitin ligase SCFGrr1 is necessary for pheromone sensitivity in Saccharomyces cerevisiae. Yeast 22 (2005) 553-564
252. Seemueller E., Lupas A., and Baumeister W. Autocatalytic processing of the 20S proteasome. Nature 382 (1996) 468-470
253. Shah S.A., Potter M.W., and Callery M.P. Ubiquitin proteasome pathway: Implications and advances in cancer therapy. Surg. Oncol. 10 (2001) 43-52
254. Sharova N.P. Immune proteasomes and immunity. Ontogenes 37 (2006) 171-178
255. Shen Y., and White E. p53-dependent apoptosis pathways. Adv. Cancer Res. 82 (2001) 55-84
256. Shibahara T., Kawasaki H., and Hirano H. Identification of the 19S regulatory particle subunits from the rice 26S proteasome. Eur. J. Biochem. 269 (2002) 1474-1483
257. Shibahara T., Kawasaki H., and Hirano H. Mass spectrometric analysis of expression of ATPase subunits encoded by duplicated genes in the 19S regulatory particle of rice 26S proteasome. Arch. Biochem. Biophys. 421 (2004) 34-41
258. Shibatani T., Nazir M., and Ward W.F. Alteration of rat liver 20S proteasome activities by age and food restriction. J. Gerontol. A Biol. Sci. Med. Sci. 51 (1996) B316-B322
259. Shim J., and Karin M. The control of mRNA stability in response to extracellular stimuli. Mol. Cells 14 (2002) 323-331
260. Shimbara N., Orino E., Sone S., Ogura T., Takashina M., Shono M., Tamura T., Yasuda H., Tanaka K., and Ichihara A. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. J. Biol. Chem. 267 (1992) 18100-18109
261. Shinohara K., Tomioka M., Nakano H., Tone S., Ito H., and Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317 (1996) 385-388
262. Shirayama M., Toth A., Galova M., and Nasmyth K. APCCdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature 402 (1999) 203-207
263. Sikder D., Johnston S.A., and Kodadek T. Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J. Biol. Chem. 281 (2006) 27346-27355
264. Smith M.W., Ito M., Miyawaki M., Sato S., Yoshikawa Y., Wada S., Maki H., Nakagawa H., and Komamine A. Plant 21D7 protein, a nuclear antigen associated with cell division, is a component of the 26S proteasome. Plant Physiol. 113 (1997) 281-291
265. Sohn D., Totzke G., Essmann F., Schulze-Osthoff K., Levkau B., and Janicke R.U. The proteasome is required for rapid initiation of death receptor-induced apoptosis. Mol. Cell Biol. 26 (2006) 1967-1978
266. Sohn D., Totzke G., Schulze-Osthoff K., and Janicke R.U. Friend or foe? The proteasome in combined cancer therapy. Cell Cycle 5 (2006) 841-845
267. Somesh B.P., Reid J., Liu W.-F., Søgaard T.M.M., Erdjument-Bromage H., Tempst P., and Svejstrup J.Q. Multiple mechanisms confi{ligature}ning RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell 121 (2005) 913-923
268. Stoebner P.E., Lavabre-Bertrand T., Henry L., Guiraud I., Carillo S., Dandurand M., Joujoux J.M., Bureau J.P., and Meunier L. High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br. J. Dermatol. 152 (2005) 948-953
269. Sumegi M., Hunyadi-Gulyas E., Medzihradszky K.F., and Udvardy A. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 312 (2003) 1284-1289
270. Sun L., Johnston S.A., and Kodadek T. Physical association of the APIS complex and general transcription factors. Biochem. Biophys. Res. Commun. 296 (2002) 991-999
271. Suzuki Y., Nakabayashi Y., and Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA 98 (2001) 8662-8667
272. Tabata M., Tabata R., Grabowski D.R., Bukowski R.M., Ganapathi M.K., and Ganapathi R. Roles of NF-kappaB and 26S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J. Biol. Chem. 276 (2001) 8029-8036
273. Takeda K., and Yanagida M. Regulation of nuclear proteasome by Rhp6/Ubc2 through ubiquitination and destruction of the sensor and anchor Cut8. Cell 122 (2005) 393-405
274. Tamura T., Nagy I., Lupas A., Lottspeich F., Cejka Z., Schoofs G., Tanaka K., De Mot R., and Baumeister W. The first characterization of a eubacterial proteasome: The 20S complex of Rhodococcus. Curr. Biol. 5 (1995) 766-774
275. Tanahashi N., Yokota K., Ahn J.Y., Chung C.H., Fujiwara T., Takahashi E., DeMartino G.N., Slaughter C.A., Toyonaga T., Yamamura K., Shimbara N., and Tanaka K. Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation. Genes Cells 2 (1997) 195-211
276. Tanaka K., Yoshimura T., Tamura T., Fujiwara T., Kumatori A., and Ichihara A. Possible mechanism of nuclear translocation of proteasomes. FEBS Lett. 271 (1990) 41-46
277. Tani E., Kitagawa H., Ikemoto H., and Matsumoto T. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells. FEBS Lett. 504 (2001) 53-58
278. Tanimoto Y., and Kizaki H. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells. J. Biochem. (Tokyo) 131 (2002) 319-326
279. Tanimoto Y., Onishi Y., Hashimoto S., and Kizaki H. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. (Tokyo) 121 (1997) 542-549
280. Tatebe H., and Yanagida M. Cut8, essential for anaphase, controls localization of 26S proteasome, facilitating destruction of cyclin and Cut2. Curr. Biol. 10 (2000) 1329-1338
281. Tewari M.K., Sinnathamby G., Rajagopal D., and Eisenlohr L.C. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6 (2005) 287-294
282. To W.Y., and Wang C.C. Identification and characterization of an activated 20S proteasome in Trypanosoma brucei. FEBS Lett. 404 (1997) 253-262
283. Toktarova M.V., Kulichkova V.A., Mittenberg A.G., Kozhukharova I.V., Volkova I.V., Ermolaeva Iu.B., Peshekhonov A.V., Ignatova T.N., Gauze L.N., and Konstantinova I.M. Selective effect of inductors of apoptosis on the endoribonuclease activity of 26S proteasomes and alpha-RNP particles in K562 cells: Possible involvement of 26S proteasomes and alpha-RNP in the regulation of RNA stability. Tsitologiia 46 (2004) 283-290 . [in Russian].
284. Tokumoto M., Horiguchi R., Nagahama Y., and Tokumoto T. Identification of the Xenopus 20S proteasome α4 subunit which is modified in the meiotic cell cycle. Gene 239 (1999) 301-308
285. Tokumoto T., Tokumoto M., Seto K., Horiguchi R., Nagahama Y., Yamada S., Ishikawa K., and Lohka M.J. Disappearance of a novel protein component of the 26S proteasome during Xenopus oocyte maturation. Exp. Cell Res. 247 (1999) 313-319
286. Tokumoto M., Horiguchi R., Nagahama Y., Ishikawa K., and Tokumoto T. Two proteins, a goldfish 20S proteasome subunit and the protein interacting with 26S proteasome, change in the meiotic cell cycle. Eur. J. Biochem. 267 (2000) 97-103
287. 2-terminal residues of rat liver proteasome (multicatalytic proteinase complex) subunits, C2, C3 and C8, are Nα-acetylated. FEBS Lett. 263 (1990) 373-375
288. Tomek W., Adam G., and Schmid H.P. Prosomes, small cytoplasmic RNP particles, contain glycoproteins. FEBS Lett. 239 (1988) 155-158
289. Tourriere H., Gallouzi I.-E., Chebli K., Capony J.P., Mouaikel J., van der Geer P., and Tazi J. RasGAP-associated endoribonuclease G3Bp: Selective RNA degradation and phosphorylation-dependent localization. Mol. Cell Biol. 21 (2001) 7747-7760
290. Tourriere H., Chebli K., and Tazi J. mRNA degradation machines in eukaryotic cells. Biochimie 84 (2002) 821-837
291. Tourriere H., Chebli K., Zekri L., Courselaud B., Blanchard J.M., Bertrand E., and Tazi J. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J. Cell Biol. 160 (2003) 823-831
292. Traenckner E.B., Wilk S., and Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13 (1994) 5433-5441
293. Tsimokha A.S., Mittenberg A.G., Kulichkova V.A., Evteeva I.N., Vatazhok Yu.Ya., Moiseeva T.N., Ermolaeva Y.B., Vashukova E.S., Volkova I.V., Kojukharova I.V., Gause L.N., and Konstantinova I.M. Specificity of the proteasome properties in diethylmaleate-induced K562 cells. Tsitologiia 48 (2006) 133-141 . [in Russian].
294. Tsimokha A.S., Mittenberg A.G., Kulichkova V.A., Kojukharova I.V., Gause L.N., and Konstantinova I.M. Changes in composition and activities of 26S proteasomes under effect of diethylmaleate: Inductor of apoptosis in erythroleukemic K562 cells. Cell Biol. Int. 31 (2007) 338-348
295. Tsimokha A.S., Mittenberg A.G., Kulichkova V.A., Vashukova E.S., Vatajok Yu.Ya., Moiseeva T.N., Evteeva I.N., Ermolaeva Yu.B., Gause L.N., and Konstantinova I.M. Reprogramming of nuclear proteasome undergoing apoptosis in K562 cells. I. Effect of glutathione-depleting agent diethylmaleate. Cell Tiss. Biol 1 (2007) 334-342
296. Tsimokha A.S., Mittenberg A.G., Evteeva I.N., Kulichkova V.A., Kojukharova I.V., Ermolaeva Yu.B., and Konstantinova I.M. Reprogramming of nuclear proteasome undergoing apoptosis in K562 cells. II. Effect of anticancer drug doxorubicin. Cell Tiss. Biol. 1 (2007) 404-411
297. Unno M., Mizushima T., Morimoto Y., Tomisugi Y., Tanaka K., Yasuoka N., and Tsukihara T. The structure of the mammalian 20S proteasome at 2.75 Å resolution. Structure (Camb.) 10 (2002) 609-618
298. Ustrell V., Hoffman L., Pratt G., and Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21 (2002) 3516-3525
299. Ustrell V., Pratt G., Gorbea C., and Rechsteiner M. Purification and assay of proteasome activator PA200. Methods Enzymol. 398 (2005) 321-329
300. Utsumi T., Sato M., Nakano K., Takemura D., Iwata H., and Ishisaka R. Amino acid residue penultimate to the aminoterminal gly residue strongly affects two cotranslational protein modifications, N-myristoylation and N-acetylation. J. Biol. Chem. 276 (2001) 10505-10513
301. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., and Miyamoto S. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev. 9 (1995) 2723-2735
302. Visintin R., Prinz S., and Amon A. CDC20 and CDH1: A family of substrate-specific activators of APC-dependent proteolysis. Science 278 (1997) 460-463
303. Viteri G., Carrard G., Birlouez-Aragon I., Silva E., and Friguet B. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch. Biochem. Biophys. 427 (2004) 197-203
304. Wada M., Kosaka M., Saito S., Sano T., Tanaka K., and Ichihara A. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance. J. Lab. Clin. Med. 121 (1993) 215-223
305. Wakata Y., Tokumoto M., Horiguchi R., Ishikawa K., Nagahama Y., and Tokumoto T. Identification of alpha-type subunits of the Xenopus 20S proteasome and analysis of their changes during the meiotic cell cycle. BMC Biochem. 5 (2004) 18
306. Wallace A.D., and Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276 (2001) 42714-42721
307. Wang H.R., Kania M., Baumeister W., and Nederlof P.M. Import of human and Thermoplasma 20S proteasomes into nuclei of HeLa cells requires functional NLS sequences. Eur. J. Cell Biol. 73 (1997) 105-113
308. Wang L., Chen L., Benincosa J., Fortney J., and Gibson L.F. VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli. Leukemia 19 (2005) 344-353
309. Wang X.W. Role of p53 and apoptosis in carcinogenesis. Anticancer Res. 19 (1999) 4759-4771
310. Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., and Huang L. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 46 (2007) 3553-3565
311. Wasch R., and Cross F.R. APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit. Nature 418 (2002) 556-562
312. Watanabe N., Arai H., Nishihara Y., Taniguchi M., Hunter T., and Osada H. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc. Natl. Acad. Sci. USA 101 (2004) 4419-4424
313. Wehren A., Meyer H.E., Sobek A., Kloetzel P.M., and Dahlmann B. Phosphoamino acids in proteasome subunits. Biol. Chem. 377 (1996) 497-503
314. Wei W., Ayad N.G., Wan Y., Zhang G.J., Kirschner M.W., and Kaelin Jr. W.G. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428 (2004) 194-198
315. Wells L., Vosseller K., Cole R.N., Cronshaw J.M., Matunis M.J., and Hart G.W. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell Proteomics 1 (2002) 791-804
316. Wojcik C. Regulation of apoptosis by the ubiquitin and proteasome pathway. J. Cell Mol. Med. 6 (2002) 25-48
317. Wojcik C., and DeMartino G.N. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 35 (2003) 579-589
318. Wojcik C., Schroeter D., Stoehr M., Wilk S., and Paweletz N. An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells. Eur. J. Cell Biol. 70 (1996) 172-178
319. Wojcik C., Benchaib M., Lornage J., Czyba J.C., and Guerin J.F. Proteasomes in human spermatozoa. Int. J. Androl. 23 (2000) 169-177
320. Wolf D.H., and Hilt W. The proteasome: A proteolytic nanomachine of cell regulation and waste disposal. Biochim. Biophys. Acta 1695 (2004) 19-31
321. Xie Y., and Varshavsky A. RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc. Natl. Acad. Sci. USA 98 (2001) 3056-3061
322. Yamano H., Gannon J., Mahbubani H., and Hunt T. Cell cycle-regulated recognition of the destruction box of cyclin B by the APC/C in Xenopus egg extracts. Mol. Cell 13 (2004) 137-147
323. Yang P., Fu H., Walker J., Papa C.M., Smalle J., Ju Y.M., and Vierstra R.D. Purification of the Arabidopsis 26S proteasome: Biochemical and molecular analyses revealed the presence of multiple isoforms. J. Biol. Chem. 279 (2004) 6401-6413
324. Yang W., Monroe J., Zhang Y., George D., Bremer E., and Li H. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett. 243 (2006) 217-227
325. Yang Y., Fang S., Jensen J.P., Weissman A.M., and Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288 (2000) 874-877
326. Yao Y., Huang L., Krutchinsky A., Wong M.L., Standing K.G., Burlingame A.L., and Wang C.C. Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei. J. Biol. Chem. 274 (1999) 33921-33930
327. Ye X., Nalepa G., Welcker M., Kessler B.M., Spooner E., Qin J., Elledge S.J., Clurman B.E., and Harper J.W. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 279 (2004) 50110-50119
328. Yen H.C., Espiritu C., and Chang E.C. Rpn5 is a conserved proteasome subunit and required for proper proteasome localization and assembly. J. Biol. Chem. 278 (2003) 30669-30676
329. Yuan X., Miller M., and Belote J.M. Duplicated proteasome subunit genes in Drosophila melanogaster encoding testesspecific isoforms. Genetics 144 (1996) 147-157
330. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
331. Zhang H., Sun L., Liang J., Yu W., Zhang Y., Wang Y., Chen Y., Li R., Sun X., and Shang Y. The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. 25 (2006) 4223-4233
332. Zong C., Gomes A.V., Drews O., Li X., Young G.W., Berhane B., Qiao X., French S.W., Bardag-Gorce F., and Ping P. Regulation of murine cardiac 20S proteasomes: Role of associating partners. Circ Res. 99 (2006) 372-380
333. Zuehl F., Tamura T., Dolenc I., Cejka Z., Nagy I., De Mot R., and Baumeister W. Subunit topology of the Rhodococcus proteasome. FEBS Lett. 400 (1997) 83-90
334. Zur A., and Brandeis M. Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO J. 20 (2001) 792-801